LAWSUIT ALERT: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation
SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on January 16th 2026 in the lawsuit that was filed for certain investors in shares of Skye Bioscience, Inc. (NASDAQ: SKYE).
Investors, who purchased between November 4, 2024 and October 3, 2025 in excess of $100,000 in shares of Skye Bioscience, Inc. (NASDAQ: SKYE), have certain options and there are short and strict deadlines running. Deadline: January 16, 2026. NASDAQ: SKYE investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On November 17, 2025, an investor in NASDAQ: SKYE shares filed a lawsuit over alleged securities laws violations by Skye Bioscience, Inc. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that nimacimab was less effective than Defendants had led investors to believe, that accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.
Those who purchased Skye Bioscience, Inc. (NASDAQ: SKYE) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
